Clinical trial

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

NCT07787936

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GLP-1 / GIP receptor agonist Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2027-01-01

PhaseN/A

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Obesityverified · MONDO: obesity disorder

Diastolic Heart Failureverified · MONDO: diastolic heart failure

Pulmonary Hypertensionverified · MONDO: pulmonary hypertension

Iron Deficiencyunresolved

Interventions

GLP-1 / GIP receptor agonistDRUG

Sponsors & collaborators

Miedziowe Centrum Zdrowia SAlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07787936 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.